(Q33357105)

English

Vinorelbine and Cisplatin for Metastatic Breast Cancer: A Salvage Regimen in Patients Progressing After Docetaxel and Anthracycline Treatment

scientific article published on January 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

Vinorelbine and cisplatin for metastatic breast cancer: a salvage regimen in patients progressing after docetaxel and anthracycline treatment (English)

1 reference

Europe PubMed Central

26 July 2017

Vinorelbine and Cisplatin for Metastatic Breast Cancer: A Salvage Regimen in Patients Progressing After Docetaxel and Anthracycline Treatment (English)

1 reference

10.1081/CNV-120022358

https://api.crossref.org/works/10.1081/CNV-120022358

19 March 2024

metastatic breast cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14533438

19 March 2024

1 reference

10.1081/CNV-120022358

https://api.crossref.org/works/10.1081/CNV-120022358

19 March 2024

author name string

M. Vassilomanolakis

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14533438

19 March 2024

G. Koumakis

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14533438

19 March 2024

M. Demiri

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14533438

19 March 2024

J. Missitzis

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14533438

19 March 2024

V. Barbounis

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14533438

19 March 2024

A. P. Efremidis

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14533438

19 March 2024

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14533438

19 March 2024

publication date

1 January 2003

1 reference

Europe PubMed Central

26 July 2017

full work available at URL

http://www.tandfonline.com/doi/pdf/10.1081/CNV-120022358

1 reference

10.1081/CNV-120022358

https://api.crossref.org/works/10.1081/CNV-120022358

19 March 2024

Cancer Investigation

1 reference

Europe PubMed Central

26 July 2017

21

1 reference

Europe PubMed Central

26 July 2017

4

1 reference

Europe PubMed Central

26 July 2017

497-504

1 reference

Europe PubMed Central

26 July 2017

Cancer of the breast: the past decade (first of two parts).

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022358

21 January 2018

Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022358

21 January 2018

Maximized reduction of primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxel

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022358

21 January 2018

Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022358

21 January 2018

Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022358

21 January 2018

Cisplatin as first-line therapy for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022358

21 January 2018

Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022358

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022358

21 January 2018

Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022358

21 January 2018

Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022358

21 January 2018

Cancer of the breast: the past decade (second of two parts)

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022358

21 January 2018

A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: report of the Clinical Screening Group of the EORTC

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022358

21 January 2018

A phase II study of the effectiveness of docetaxel (Taxotere) in women with advanced breast cancer previously treated with polychemotherapy. Hellenic Cooperative Interhospital Group in Oncology

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022358

21 January 2018

CD40 is functionally expressed on human breast carcinomas: variable inducibility by cytokines and enhancement of Fas-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022358

21 January 2018

Combination versus sequential doxorubicin and docetaxel as primary chemotherapy for breast cancer: A randomized pilot trial of the Hoosier Oncology Group

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022358

21 January 2018

Phase II clinical trial of cis-dichlorodiammine platinum (cis-DDP) for antitumorigenic activity in previously untreated patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022358

21 January 2018

Salvage therapies in women who fail to respond to first-line treatment with fluorouracil, epirubicin, and cyclophosphamide for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022358

21 January 2018

Paclitaxel activity in heavily pretreated breast cancer: a National Cancer Institute Treatment Referral Center trial

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022358

21 January 2018

A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group

3

1 reference

10.1081/CNV-120022358

https://api.crossref.org/works/10.1081/CNV-120022358

19 March 2024

Drugs ten years later: epirubicin.

4

1 reference

10.1081/CNV-120022358

https://api.crossref.org/works/10.1081/CNV-120022358

19 March 2024

Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer

6

1 reference

10.1081/CNV-120022358

https://api.crossref.org/works/10.1081/CNV-120022358

19 March 2024

Identifiers

10.1081/CNV-120022358

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33357105&oldid=2105698320"